Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2021
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2021
Insights into the Single Nucleotide Polymorphism (SNP) Genotyping Market include supply chain optimization, Single Nucleotide Polymorphism (SNP) Genotyping challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Single Nucleotide Polymorphism (SNP) Genotyping Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Overview:
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Single Nucleotide Polymorphism (SNP) Genotyping involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Single Nucleotide Polymorphism (SNP) Genotyping Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Single Nucleotide Polymorphism (SNP) Genotyping market in 2020.
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation
By Type, Single Nucleotide Polymorphism (SNP) Genotyping market has been segmented into:
Transversion
Transition
By Application, Single Nucleotide Polymorphism (SNP) Genotyping market has been segmented into:
Diagnostics
Animal
Plant
Research
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Single Nucleotide Polymorphism (SNP) Genotyping market are:
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
1. Market Overview of Single Nucleotide Polymorphism (SNP) Genotyping
1.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
1.1.1 Single Nucleotide Polymorphism (SNP) Genotyping Product Scope
1.1.2 Market Status and Outlook
1.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Regions (2015-2020)
1.4 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Single Nucleotide Polymorphism (SNP) Genotyping Sales Market by Type (2015-2026)
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2015-2020)
2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2021-2026)
2.3 Transversion
2.4 Transition
3. Covid-19 Impact Single Nucleotide Polymorphism (SNP) Genotyping Sales Market by Application (2015-2026)
3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2015-2020)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2021-2026)
3.3 Diagnostics
3.4 Animal
3.5 Plant
3.6 Research
3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Single Nucleotide Polymorphism (SNP) Genotyping Business
5.1 Illumina
5.1.1 Illumina Company Profile
5.1.2 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Affymetrix
5.2.1 Affymetrix Company Profile
5.2.2 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Applied Biosystems
5.3.1 Applied Biosystems Company Profile
5.3.2 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Agilent Technologies
5.4.1 Agilent Technologies Company Profile
5.4.2 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Beckman Coulter
5.5.1 Beckman Coulter Company Profile
5.5.2 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Roche
5.6.1 Roche Company Profile
5.6.2 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Qiagen
5.7.1 Qiagen Company Profile
5.7.2 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Luminex Corporation
5.8.1 Luminex Corporation Company Profile
5.8.2 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Enzo Life Sciences
5.9.1 Enzo Life Sciences Company Profile
5.9.2 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Bio-rad
5.10.1 Bio-rad Company Profile
5.10.2 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Sequenom
5.11.1 Sequenom Company Profile
5.11.2 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Ocimum Biosolutions
5.12.1 Ocimum Biosolutions Company Profile
5.12.2 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 GE Healthcare
5.13.1 GE Healthcare Company Profile
5.13.2 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 GenScript
5.14.1 GenScript Company Profile
5.14.2 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Douglas Scientific
5.15.1 Douglas Scientific Company Profile
5.15.2 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 BGI
5.16.1 BGI Company Profile
5.16.2 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Beijing Sunbiotech
5.17.1 Beijing Sunbiotech Company Profile
5.17.2 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 HuaGene Biotech
5.18.1 HuaGene Biotech Company Profile
5.18.2 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Generay Biotech
5.19.1 Generay Biotech Company Profile
5.19.2 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Benegene
5.20.1 Benegene Company Profile
5.20.2 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 Shanghai Biochip
5.21.1 Shanghai Biochip Company Profile
5.21.2 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 GENESKY
5.22.1 GENESKY Company Profile
5.22.2 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 HD Biosciences
5.23.1 HD Biosciences Company Profile
5.23.2 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Specification
5.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
7.2 East Asia Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
7.3 East Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
7.4 East Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
8. Europe
8.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
8.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
8.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
8.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
9.2 South Asia Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
9.3 South Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
9.4 South Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
10.2 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
10.3 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
10.4 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
11.2 Middle East Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
11.3 Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
11.4 Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
12. Africa
12.1 Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
12.2 Africa Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
12.3 Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
12.4 Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
13.2 Oceania Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
13.3 Oceania Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
13.4 Oceania Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
14. South America
14.1 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
14.2 South America Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
14.3 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
14.4 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2015-2026)
15.2 Rest of the World Single Nucleotide Polymorphism (SNP) Genotyping Key Players in North America (2015-2020)
15.3 Rest of the World Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2015-2020)
15.4 Rest of the World Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2015-2020)
16 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Single Nucleotide Polymorphism (SNP) Genotyping Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|